There are 2 talks: UK positioning as a cancer vaccine superpower- hyperbole or reality? Infinitopes as a CRUK-led cancer vaccine spinout from the Oxford ecosystem
The United Kingdom has announced plans for a Cancer Vaccine launchpad, to advance and build on lessons learnt during the pandemic. Is the UK the best place for cancer vaccine innovation and trials? What are the hurdles to the UK establishing itself as a cancer vaccine science superpower?

Infinitopes are a team of expert doctors and scientists, from Oxford University’s oncology, immunology, antigen discovery, vaccinology & biomanufacturing departments, pushing the boundaries of science & medicine, to identify hidden tumour targets, enabling us to create high efficiency vaccines.
Date: 1 June 2023, 12:00 (Thursday, 6th week, Trinity 2023)
Venue: IMS-Tetsuya Nakamura Building, Roosevelt Dr, Headington OX3 7TY
Venue Details: Large Seminar Room on ground floor
Speakers: Dr Lennard Lee (University of Oxford), Dr Jonathan Kwok (Infinitopes)
Organising department: Divisional Office (MSD)
Organisers: Denitsa Filipova (Business Partnerships Office), Sheena Lee (MSD Business Partnerships Office), Medical Sciences Division Business Partnerships Office (University of Oxford)
Organiser contact email address: sheena.lee@medsci.ox.ac.uk
Host: Denitsa Filipova (Business Partnerships Office)
Part of: Industry Insight Seminar Series
Booking required?: Required
Booking url: https://www.eventbrite.co.uk/e/industry-insights-seminar-series-tickets-131313804123
Cost: Free
Audience: Members of the University of Oxford and the Oxford BioEscalator
Editor: Sheena Lee